h******y
发帖数: 351 | 1 "Robin Smith, chief executive at Neostem, disagrees. She compares the attack
s on VSELs to those suffered by Charles Darwin and Nicolaus Copernicus when
they proposed their world-changing scientific theories."
看到这儿就笑了。这么自信的多半真不了。 |
|
f**********g
发帖数: 2252 | 2 $1,700,000 Funding of NeoStem's Very Small Embryonic-Like Stem Cells Being
Developed to Treat Osteoporosis Recommended by the Department of Defense
Peer Reviewed Medical Research Program
41 minutes ago - PRN
PR NewswireNeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an
international biopharmaceutical company with operations in the U.S. and
China, today announced that its FY2010 Technology/Therapeutic Development
Award application number PR101055 has been recommended for funding by t... 阅读全帖 |
|
f**********g
发帖数: 2252 | 3 $1,700,000 Funding of NeoStem's Very Small Embryonic-Like Stem Cells Being
Developed to Treat Osteoporosis Recommended by the Department of Defense
Peer Reviewed Medical Research Program
41 minutes ago - PRN
PR NewswireNeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an
international biopharmaceutical company with operations in the U.S. and
China, today announced that its FY2010 Technology/Therapeutic Development
Award application number PR101055 has been recommended for funding by t... 阅读全帖 |
|
发帖数: 1 | 4 设计
M777最初是由VSEL在英国Barrow-in-Furness的军备部门所研发的超轻量野战榴弹炮（
Ultralight-weight Field Howitzer，简称UFH）。VSEL在1999年被BAE合并，公司改名
为BAE Systems RO Defence，原单位则在2004年编制成为BAE陆战系统（BAE Systems
Land Systems）的一环。BAE原先的合作伙伴是美国的联合防御公司（United Defense
），然而BAE在2005年将其并购，并透过其美国系统的BAE陆战与军备集团（BAE
Systems Land and Armaments group）开始负责设计、制造与组装的业务。因此M777约
有70%的零件，包括炮管，是在美国Watervliet Arsenal所制造。
M777总重不到4100公斤，使用M107炮弹射程达20公里以上，当使用弹底喷气弹时射程同
样达30公里，与M198同级的射程，但体积较为小巧并轻上42%。减轻重量的关键要归因
炮架采用钛合金等轻金属兼顾重量与强度，却也因此造价大增。相较于M198，M777轻巧
的身... 阅读全帖 |
|
|
m***a
发帖数: 547 | 6 感觉？
有自身经验末有？
attack
when |
|
h******y
发帖数: 351 | 7 四家不同的实验室都不能重复，连自己人都反水，你说能是真的吗。 |
|
H**O
发帖数: 89 | 8 Vacanti是她老板 Vacanti自己的什么孢子细胞（85度5分钟杀不死的细胞）、VSELs细
胞（直径5微米的类胚胎干细胞），没人能重复。他也是这两篇文章中的一篇的署名者。
小保方在Vacanti的2011年文章有图片造假，也是在Vacanti那里读博士的时候发布的
Vacanti能重复，说明不了问题。 |
|
|
|
f**********g
发帖数: 2252 | 11 Anyone familiar with NBS?
http://finviz.com/screener.ashx?v=341&t=NBS
NeoStem to Present at Two Investor Conferences in San Francisco on Wednesday
, January 12, 2011
1 hours 20 minutes ago - PRN
PR NewswireNeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an
international biopharmaceutical company with operations in the U.S. and
China, today announced that Dr. Robin Smith, the Company's Chairman and CEO,
will present on Wednesday, January 12, 2011 at the OneMedForum 2011 at 9:15
AM PS... 阅读全帖 |
|
f**********g
发帖数: 2252 | 12 Anyone familiar with NBS?
http://finviz.com/screener.ashx?v=341&t=NBS
NeoStem to Present at Two Investor Conferences in San Francisco on Wednesday
, January 12, 2011
1 hours 20 minutes ago - PRN
PR NewswireNeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an
international biopharmaceutical company with operations in the U.S. and
China, today announced that Dr. Robin Smith, the Company's Chairman and CEO,
will present on Wednesday, January 12, 2011 at the OneMedForum 2011 at 9:15
AM PS... 阅读全帖 |
|
f**********g
发帖数: 2252 | 13 anyone familar?
Progenitor Cell Therapy to Present at 6th Annual New York Stem Cell Summit
on Tuesday, March 1
1 days 6 hours 27 minutes ago - EUR via Comtex
PR Newswire EuropeNeoStem, Inc. , an international biopharmaceutical company
with operations in the U.S. and China, announced today that Dr. Robert
Preti, PhD, President and Chief Scientific Officer of Progenitor Cell
Therapy ("PCT"), a wholly-owned subsidiary of NeoStem, Inc., has been asked
to present on Tuesday, March 1, 2011 at the 6th ... 阅读全帖 |
|
f**********g
发帖数: 2252 | 14 anyone familar?
Progenitor Cell Therapy to Present at 6th Annual New York Stem Cell Summit
on Tuesday, March 1
1 days 6 hours 27 minutes ago - EUR via Comtex
PR Newswire EuropeNeoStem, Inc. , an international biopharmaceutical company
with operations in the U.S. and China, announced today that Dr. Robert
Preti, PhD, President and Chief Scientific Officer of Progenitor Cell
Therapy ("PCT"), a wholly-owned subsidiary of NeoStem, Inc., has been asked
to present on Tuesday, March 1, 2011 at the 6th ... 阅读全帖 |
|
